Regulation of Downstream Targets

1. Transcriptional regulatory mechanisms and signaling networks in cancer<br>Chandrabose Selvaraj, Karthik Raja Ramalingam, Devadasan Velmurugan, and Sanjeev Kumar Singh<br>2. Identification of dysregulated canonical pathways associated with pathogenesis and progression of Amyotrophic Lateral Sclerosis—An integrated bioinformatics approach<br>Ankur Datta, S. Udhaya Kumar, Maria D'costa, Anusha Bothe, D. Thirumal Kumar, Hatem Zayed, and C. George Priya Doss<br>3. Elucidating the mechanism of antimicrobial resistance in Mycobacterium tuberculosis using gene interaction networks<br>Keerthana G., Karthick Vasudevan, Hrituraj Dey, Tasmia Kausar, S. Udhaya Kumar, D. Thirumal Kumar, Hatem Zayed, and C. George Priya Doss<br>4. AMPK-like proteins and their function in female reproduction and gynecologic cancer<br>Claire Baumgartner, Anil Kumar Yadav, and Ilana Chefetz<br>5. A compilation of bioinformatic approaches to identify novel downstream targets for the detection and prophylaxis of cancer<br>Mangala Hegde, Sosmitha Girisa, and Ajaikumar B. Kunnumakkara<br>6. Protein phosphatases and their targets: Comprehending the interactions in plant signaling pathways<br>Lokesh K. Saini, Malathi Bheri, and Girdhar K. Pandey<br>7. Calcium decoders and their targets: The holy alliance that regulate cellular responses in stress signaling<br>Barkha Ravi, Sibaji K. Sanyal, and Girdhar K. Pandey<br>8. Importin alpha family NAAT/IBB domain: Functions of a pleiotropic long chameleon sequence<br>Kazuya Jibiki, Takashi S. Kodama, and Noriko Yasuhara<br>9. AURORA KINASE A and related downstream molecules: A potential network for cancer therapy<br>Homa Fatma, and Hifzur R. Siddique<br>10. Emerging role of heat shock proteins in cardiovascular diseases<br>Joyita Hazra, Anupama Vijayakumar, and Nitish R. Mahapatra<br>11. Function, structure, evolution, regulation of a potent drug target, arylalkylamine N-acetyltransferase<br>Lei Zhang, Yu Tang, David J. Merkler, and Qian Han<br>12. Analysis of signaling cascades from myeloma cells treated with pristimerin<br>Heba Almaghrbi, Rehab Elkardawy, S. Udhaya Kumar, Shilpa Kuttikrishnan, Taghreed Abunada, Manoj Kumar Kashyap, Aamir Ahmad, Shahab Uddin, C. George Priya Doss, and Hatem Zayed<br>13. Mixed lineage kinase domain-like pseudokinase: Conventional (necroptosis) and unconventional (necroptosisindependent) functions and features<br>Tuna Onal, Melike Ozgul-Onal, and Ilana Chefetz<br>